Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DWJ3A7
|
|||
| Drug Name |
DS-2969
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Clostridium infection [ICD-11: 1A04; ICD-10: A04.7] | Phase 1 | [1] | |
| Company |
Daiichi Sankyo
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Clostridium difficile DNA gyrase (CD gyr) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | In Vitro and In Vivo Activities of DS-2969b, a Novel GyrB Inhibitor, against Clostridium difficile. Antimicrob Agents Chemother. 2018 Mar 27;62(4):e02157-17. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.